Life ScienceCompany
OSI Pharmaceuticals M&A Summary
OSI Pharmaceuticals has acquired 3 companies of its own. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
OSI Pharmaceuticals’ largest acquisition to date was in 2005, when it acquired Eyetech Pharmaceuticals for $935M. It’s largest disclosed sale occurred in 2012, when it sold Eyetech Pharmaceuticals to Bausch Health Companies for $22M. OSI Pharmaceuticals has acquired in 3 different US states. The Company’s most targeted sectors include life science (100%).
OSI Pharmaceuticals Ownership
Who owns OSI Pharmaceuticals?
OSI Pharmaceuticals is owned by Astellas Pharma. It was acquired on June 9, 2010.
OSI Pharmaceuticals Business Overview
Where is OSI Pharmaceuticals headquartered?
OSI Pharmaceuticals is headquartered in Farmingdale, New York.
What sector is OSI Pharmaceuticals in?
OSI Pharmaceuticals is a life science company.
When was OSI Pharmaceuticals founded?
OSI Pharmaceuticals was founded in 1983.
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity3
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 3
- M&A Advisors 1
Unlimited Searches
